This CPB has been revised to state that biofeedback is considered experimental and investigational for the treatment of Bell's palsy and for childhood apraxia of speech. These policy revisions are supported by the conclusions of Cochrane reviews. This CPB is revised to state that biofeedback is considered experimental and investigational for cardiovascular diseases.